Inspire Medical Systems, Inc. INSP
Set alert
68.10 USD -3.08 -4.33%
At close · Oct 30
68.10 0.00 0.00%
After hours · Oct 30, 5:05 PM ET
67.80 Day range 71.20
40.05 52-week range 143.99
- YTD
- -26.16%
- 1 year
- -6.80%
- Open
- 70.63
- Prev close
- 71.18
- Mkt cap
- 1.97B
- Vol
- 796.40K
- Avg vol
- 772.91K
- EPS
- 4.54
- P/E
- 15.00
- Div yield
- 0.00%
More statistics
- Low
- 67.80
- High
- 71.20
- Forward P/E
- 44.32
- Beta
- 0.73
- Short ratio
- 4.74
- Inst. own
- 129.28%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 2, 2026
- 50-d avg
- 68.45
- 200-d avg
- 58.70
- 1y target
- 68.00
2Y chart
Events in this range
- Aug 4, 2025Earnings: 0.45; estimate 0.22; surprise 104.55%
- Nov 3, 2025Earnings: 0.38; estimate -0.15; surprise 353.33%
- Feb 11, 2026Earnings: 1.65; estimate 0.69; surprise 139.13%
- May 4, 2026Earnings: 0.1; estimate -0.27533; surprise 136.32%
- Aug 3, 2026Earnings: 0.14; estimate -0.23592; surprise 159.34%
- Sep 11, 2026Rating: Stifel · Buy → Buy
- Sep 21, 2026Rating: Freedom Capital Markets · Buy → Buy
- Oct 1, 2026Rating: RBC Capital · Sector Perform → Sector Perform
- Oct 2, 2026Rating: Freedom Capital Markets · Buy → Buy
- Oct 7, 2026Rating: Barclays · — → Underweight
- Oct 14, 2026Rating: Truist Securities · Hold → Hold
Signals (69)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 1 day ago |
| MACD: Sell Signal | Oct 26, 2026 | 5 days ago |
| MACD: Buy Signal | Oct 22, 2026 | 1 week ago |
| MACD: Sell Signal | Sep 23, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 10, 2026 | 1 month ago |
| RSI: Overbought | Sep 10, 2026 | 1 month ago |
| SMA: Bullish | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 26, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 20, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 14, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 4, 2026 | 2 months ago |
| RSI: Overbought | Aug 4, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 24, 2026 | 3 months ago |
| RSI: Overbought | Jul 9, 2026 | 3 months ago |
| SMA: Bullish | Jul 1, 2026 | 4 months ago |
| MACD: Buy Signal | May 22, 2026 | 5 months ago |
| RSI: Oversold | May 15, 2026 | 5 months ago |
| RSI: Oversold | May 13, 2026 | 5 months ago |
| RSI: Oversold | May 8, 2026 | 5 months ago |
| MACD: Sell Signal | May 5, 2026 | 5 months ago |
| MACD: Buy Signal | Mar 31, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 23, 2026 | 7 months ago |
| RSI: Oversold | Mar 23, 2026 | 7 months ago |
| MACD: Buy Signal | Feb 23, 2026 | 8 months ago |
| RSI: Oversold | Feb 2, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 22, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 20, 2026 | 9 months ago |
| SMA: Bearish | Dec 18, 2025 | 10 months ago |
| SMA: Bearish | Dec 15, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 15, 2025 | 10 months ago |
| SMA: Bullish | Nov 25, 2025 | 11 months ago |
| RSI: Overbought | Nov 24, 2025 | 11 months ago |
| SMA: Bullish | Nov 4, 2025 | 12 months ago |
| MACD: Buy Signal | Nov 4, 2025 | 12 months ago |
| MACD: Sell Signal | Oct 30, 2025 | 1 year ago |
| SMA: Bearish | Oct 22, 2025 | 1 year ago |
| SMA: Bullish | Oct 21, 2025 | 1 year ago |
| RSI: Oversold | Oct 1, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 20, 2025 | 1 year ago |
| RSI: Oversold | Aug 14, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 5, 2025 | 1 year ago |
| RSI: Oversold | Aug 5, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 22, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 21, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 23, 2025 | 1 year ago |
| RSI: Oversold | Jun 12, 2025 | 1 year ago |
| RSI: Oversold | Jun 2, 2025 | 1 year ago |
| MACD: Sell Signal | May 15, 2025 | 1 year ago |
| SMA: Bearish | May 14, 2025 | 1 year ago |
| SMA: Bullish | May 13, 2025 | 1 year ago |
| SMA: Bearish | May 7, 2025 | 1 year ago |
| SMA: Bullish | May 6, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 15, 2025 | 1 year ago |
| RSI: Oversold | Apr 4, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 27, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 25, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 5, 2025 | 1 year ago |
| SMA: Bearish | Feb 27, 2025 | 1 year ago |
| SMA: Bullish | Feb 26, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 26, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 7, 2025 | 1 year ago |
| SMA: Bearish | Feb 6, 2025 | 1 year ago |
| SMA: Bullish | Jan 28, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 28, 2025 | 1 year ago |
| SMA: Bearish | Jan 23, 2025 | 1 year ago |
| SMA: Bullish | Jan 22, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 14, 2025 | 1 year ago |
| RSI: Overbought | Jan 7, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 3, 2025 | 1 year ago |
Key statistics
- Market cap
- 1.97B
- Enterprise value
- 1.77B
- Trailing P/E
- 15.00
- Forward P/E
- 44.32
- PEG ratio
- 0.00
- Price / sales
- 2.19
- Price / book
- 2.38
- EPS (TTM)
- 4.54
- Beta
- 0.73
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 15.03%
- Revenue (TTM)
- 898.74M
- Revenue growth
- -7.60%
- Free cash flow
- 94.64M
- Total cash
- 320.68M
- Total debt
- 29.09M
- Return on equity
- 17.97%
- Shares outstanding
- 28.91M
- Short % of float
- 20.34%
- 50-day average
- 68.45
- 200-day average
- 58.70
Analyst view
Consensus: hold
Hold
Price target (mean) 68.00 -0.1% downside
Now 68.10
- Target (low)
- 40.00
- Target (mean)
- 68.00
- Target (high)
- 97.00
Ratings (0m) 18 4 buy · 11 hold · 3 sell
- Strong buy0
- Buy4
- Hold11
- Sell1
- Strong sell2
Next earnings
Nov 2, 2026
Expected Nov 2, 2026. Consensus EPS estimate 0.09087.
Financials — quick view
INSP Revenue — quarterly 200.58M
INSP Net income — quarterly 314.00K
INSP EPS — quarterly 0.01
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 2, 2026 | Sep 30, 2026 | 0.08701 | — | — | — |
| Aug 3, 2026 | Jun 30, 2026 | -0.23592 | 0.14 | +0.38 | +159.34% |
| May 4, 2026 | Mar 31, 2026 | -0.27533 | 0.10 | +0.38 | +136.32% |
| Feb 11, 2026 | Dec 31, 2025 | 0.69 | 1.65 | +0.96 | +139.13% |
| Nov 3, 2025 | Sep 30, 2025 | -0.15 | 0.38 | +0.53 | +353.33% |
| Aug 4, 2025 | Jun 30, 2025 | 0.22 | 0.45 | +0.23 | +104.55% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 14, 2026 | Truist Securities | main | Hold | Hold |
| Oct 7, 2026 | Barclays | init | — | Underweight |
| Oct 2, 2026 | Freedom Capital Markets | main | Buy | Buy |
| Oct 1, 2026 | RBC Capital | main | Sector Perform | Sector Perform |
| Sep 21, 2026 | Freedom Capital Markets | main | Buy | Buy |
| Sep 11, 2026 | Stifel | main | Buy | Buy |
About Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- inspiresleep.com
News
- INSP Stock Gains 47.8% in Three Months: What's Driving the Rally?
- Truist Securities Maintains Hold on Inspire Medical Systems, Raises Price Target to $78
- Inspire Medical Systems Inc (INSP) Stock Up 3.3% and Still Undervalued -- GF Score: 64/100
- Barclays Initiates Coverage On Inspire Medical Systems with Underweight Rating, Announces Price Target of $65
- Roche Diagnostics delivers laboratory equipment to support Ebola testing in DRC
- Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026
- Inspire Medical Gains New CPT Codes for Hypoglossal Nerve Stimulation
- Inspire Medical Systems Receives American Medical Association CPT Editorial Panel Approval To Establish New Set Of Current Procedural Terminology Codes
- Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel
- RBC Capital Maintains Sector Perform on Inspire Medical Systems, Raises Price Target to $75
Your note
Sign in to keep a note on INSP — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BUCHHOLZ RICHARD | Chief Financial Officer | Sale | Aug 28, 2025 | 50,767 |
| HERBERT TIMOTHY P | Chief Executive Officer | Stock Award(Grant) | Feb 19, 2026 | 163,492 |
| KELLY JASON P | Officer | Sale | Aug 6, 2026 | 18,985 |
| MANN MELISSA | Officer | Stock Award(Grant) | Feb 19, 2026 | 23,609 |
| MCCORMICK SHAWN T | Director | Sale | May 7, 2026 | 30,712 |
| MEAD DANA G JR | Director | Stock Award(Grant) | Apr 29, 2026 | 26,213 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 16.39% | 4,737,519 | 322.61M | Jun 29, 2026 |
| Wellington Management Group, LLP | 8.24% | 2,382,660 | 162.25M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 7.23% | 2,088,961 | 142.25M | Jun 29, 2026 |
| Soleus Capital Management, L.P. | 6.68% | 1,931,436 | 131.53M | Jun 29, 2026 |
| AQR Capital Management, LLC | 6.42% | 1,856,800 | 126.44M | Jun 29, 2026 |
| UBS Group AG | 5.69% | 1,645,511 | 112.06M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 7.24% | 2,093,826 | 142.58M | Jul 30, 2026 |
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.95% | 1,720,772 | 117.18M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.16% | 914,149 | 62.25M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.59% | 750,208 | 51.09M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.28% | 660,263 | 44.96M | Jun 29, 2026 |
| Artisan Partners Funds Inc.-Artisan International Small-Mid Fund | 1.58% | 456,014 | 31.05M | Jun 29, 2026 |